A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries?
HIV prevention
Posted inNPR
Ukraine keeps up the fight against HIV while fighting a war
Progress in preventing infections was being made in the country with Europe’s second-highest number of HIV cases. Then came the Russian invasion.
Posted inNPR
A new way to prevent HIV delivers dramatic results in trial
The testing of lenacapavir was halted because results were so impressive — 100% effectiveness. The decision was made to give all participants the injection rather than the alternative daily pill.
Posted inNPR
Hydeia Broadbent, a prominent HIV/AIDS activist, dies at 39
Broadbent, diagnosed at age 3, was one of the first generation of children born HIV positive, and known for raising awareness to lessen the stigma of the disease from a young age. She died Tuesday.
